EU regulator backs Takeda's dengue vaccine
3 minute readPublished: Friday, October 14, 2022 at 10:35 am
/cloudfront-us-east-2.images.arcpublishing.com/reuters/JIWT4VMMFZMYNIVD3VNO6F4G7A.jpg)
Advisers to the European Medicines Agency (EMA) on Friday backed the use of a tetravalent dengue vaccine by the German unit of Japan's Takeda for people aged four years and above.